Updated:
Hildred Capital Partners
Hildred Capital Partners was established in 2014 by Howard Solomon, former CEO of Forest Laboratories, and his son David Solomon. The wealth originated from...
Hildred Capital Partners
Hildred Capital Partners was established in 2014 by Howard Solomon, former CEO of Forest Laboratories, and his son David Solomon. The wealth originated from the 2014 sale of Forest Laboratories to Actavis. The firm operates as the dedicated vehicle for the Solomon family in New York. The office allocates across private equity, public markets, private credit, and direct co-investments. Buyout and growth equity stages receive primary attention. Confirmed positions include healthcare services and biotech platforms. Geographies span North America and Europe. Co-investors such as Athyrium Capital Management appear alongside Hildred in multiple healthcare transactions. The team includes Andrew Goldman as co-founder and chief investment officer. Additional partners such as Stephen Hallenbeck support operations. No secondary offices are recorded. Philanthropic vehicles include the Solomon Center for Health Law & Policy at Yale Law School and The Triangle Fund. David Solomon serves as president of the board at Lincoln Center Theater. The family-office architecture keeps investment decisions inside a single principal group rather than an external manager platform. This setup allows direct oversight of both liquid and illiquid positions without external fund commitments. Governance remains tied to the founding family branch.
General information
Firm type
Single Family Office
Year founded
2014
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Howard Solomon
Founder
David Solomon
Founder and Managing Partner
Andrew Goldman
Co-founder and Chief Investment Officer
Stephen Hallenbeck
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Hildred Capital Partners?
David Solomon serves as managing partner alongside co-founder Andrew Goldman as chief investment officer. Howard Solomon participates as founder. Decisions stay within this core group.
Where does the underlying wealth come from?
The capital stems from the 2014 sale of Forest Laboratories to Actavis for $28 billion. Howard Solomon led the company as CEO prior to the transaction.
Does Hildred Capital Partners participate in fund commitments or only direct deals?
The firm executes direct co-investments, SPVs, private credit, and secondaries alongside selected public-market holdings. External fund commitments are not the primary vehicle.
What investment stages does Hildred Capital Partners typically target?
Buyout and growth equity stages form the core focus. Distressed and turnaround situations also appear in the mandate.
Which sectors does Hildred Capital Partners explicitly focus on?
Healthcare services, digital health, biotech, insurtech, agritech, and cannabis receive explicit allocation. AI/ML and enterprise software appear as supporting technology exposures.
How is Hildred Capital Partners related to Athyrium Capital Management?
Athyrium serves as a frequent co-investment partner in healthcare deals. The relationship is documented through multiple joint transactions.
Does Hildred Capital Partners maintain philanthropic structures?
Yes. The Solomon Center for Health Law & Policy at Yale Law School and The Triangle Fund operate as separate philanthropic entities. Family members also hold board roles at Lincoln Center Theater and the Metropolitan Opera.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: